BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34512761)

  • 1. Investigating the Application of Liposomes as Drug Delivery Systems for the Diagnosis and Treatment of Cancer.
    Allahou LW; Madani SY; Seifalian A
    Int J Biomater; 2021; 2021():3041969. PubMed ID: 34512761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi S; Oyelere AK
    Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Cancer Therapy Using Multifunctional Liposomes.
    Jain A; Tiwari A; Verma A; Saraf S; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):105-134. PubMed ID: 32865902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
    Maranhão RC; Vital CG; Tavoni TM; Graziani SR
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1217-1226. PubMed ID: 28042707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization.
    van der Koog L; Gandek TB; Nagelkerke A
    Adv Healthc Mater; 2022 Mar; 11(5):e2100639. PubMed ID: 34165909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes for Antibiotic Encapsulation and Delivery.
    Gonzalez Gomez A; Hosseinidoust Z
    ACS Infect Dis; 2020 May; 6(5):896-908. PubMed ID: 32208673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections.
    Wang DY; van der Mei HC; Ren Y; Busscher HJ; Shi L
    Front Chem; 2019; 7():872. PubMed ID: 31998680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Liposomes for Lung Cancer Therapy.
    Shahid A; Khan MM; Ahmad U; Haider MF; Ali A
    Crit Rev Ther Drug Carrier Syst; 2022; 39(4):1-47. PubMed ID: 35695657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
    Das RP; Gandhi VV; Singh BG; Kunwar A
    Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update.
    Abdulbaqi IM; Assi RA; Yaghmur A; Darwis Y; Mohtar N; Parumasivam T; Saqallah FG; Wahab HA
    Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as nanocarriers for anti-HIV therapy.
    Chopra S; Venkatesan N; Betageri GV
    Drug Deliv Transl Res; 2013 Oct; 3(5):471-8. PubMed ID: 25788354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
    Haider M; Abdin SM; Kamal L; Orive G
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
    Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
    J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes in Active, Passive and Acoustically-Triggered Drug Delivery.
    Basha SA; Salkho N; Dalibalta S; Husseini GA
    Mini Rev Med Chem; 2019; 19(12):961-969. PubMed ID: 30961495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes as biocompatible and smart delivery systems - the current state.
    Dymek M; Sikora E
    Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.